Chief medical officer / svp clinical development (m/f/d)
ZürichSJP Biotec GmbH
Introduction About SJP Biotec SJP Biotec GmbH is a clinical-stage precision oncology company pioneering a first-in-class Selective Translation Regulatory Inhibitor (STRI) platform powered to overcome treatment resistance in refractory cancers. Founded in 2024, SJP targets RAS-driven, hormone-receptor-positive, and immune-refractory tumors with a [...]